A Case Report of Futibatinib-Induced Calciphylaxis

Authors

  • Colin P. Slaymaker, MS-4 University of Kansas School of Medicine
  • Haoran Li, M.D., Ph.D. University of Kansas Cancer Center

DOI:

https://doi.org/10.17161/kjm.vol18.22862

Keywords:

Calciphylaxis, Cholangiocarcinoma, Molecular Targeted Therapies

Metrics

File downloads
53
Feb 19 '25Feb 22 '25Feb 25 '25Feb 28 '25Mar 01 '25Mar 04 '25Mar 07 '25Mar 10 '25Mar 13 '25Mar 16 '254.0
|

Downloads

Published

2025-02-17

Issue

Vol. 18 No. 1 (2025): Jan. - Feb.

Section

Case Reports

License

Copyright (c) 2025 Colin P. Slaymaker, MS-4, Haoran Li, M.D., Ph.D.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Slaymaker, C., & Li, H. (2025). A Case Report of Futibatinib-Induced Calciphylaxis. Kansas Journal of Medicine, 18(1), 25-27. https://doi.org/10.17161/kjm.vol18.22862